DR. BRUCE E HUDKINS, MD
Medical Practice at Olympia Ave, Tulsa, OK

6763973, Jul 20, 2004

Jul 15, 2002

10/195581

Bruce Eric Hudkins - Tulsa OK 74120

G01F 1100

222 1, 222 92, 222143, 22215309, 222209, 222633

An expandable single use liquid containment vessel that can fit into restricted spaces such as the trunk or glove compartment of a passenger transport vehicle. The vessel contains a top and bottom wall integrally connected via an outer wall embodying accordion type pleats to allow for vessel compression and expansion. A single piece pouring nozzle is permanently attached to the containment vessel subsequent to introduction of a fluid the containment vessels interior portion. One end of the filling nozzle secures the nozzle to the containment vessel. At the second end of the nozzle is an exiting orifice which has been dimensioned to preclude insertion therein of publicly accessible fueling nozzles commonly associated with motor vehicle refueling stations.

2011023, Sep 22, 2011

Jun 2, 2011

13/109623

Bruce Eric Hudkins - Tulsa OK, US

A01H 5/00, C12N 5/10, A01H 5/10

800298, 435419

Transgenic plants, and a method for making the same, wherein genes encoding the enzyme luciferase and its corresponding substrate luciferin are incorporated into a native plant genome. Once transformed into plant cells, these genes may be regulated such that under certain endogenous or exogenous conditions, their expression in the mature plant results in bioluminescence. Different luciferin/luciferase complexes and/or mechanisms of regulation may be utilized for these transgenic plants, depending on a variety of factors such as plant species and the circumstances under which a biolmuniescent reaction is desired. Phototransformation may be utilized to vary the wavelength of light emitted from the mature plant.

7994396, Aug 9, 2011

Feb 11, 2010

12/704330

Bruce Eric Hudkins - Tulsa OK, US

C12N 15/82, C12N 15/31, C12N 15/53, C12N 15/62, A01H 5/00

800282, 800287, 800288, 800303, 435 8, 435 698, 435189, 435468

Transgenic plants, and a method for making the same, wherein genes encoding the enzyme luciferase and its corresponding substrate luciferin are incorporated into a native plant genome. Once transformed into plant cells, these genes may be regulated such that under certain endogenous or exogenous conditions, their expression in the mature plant results in bioluminescence. Different luciferin/luciferase complexes and/or mechanisms of regulation may be utilized for these transgenic plants, depending on a variety of factors such as plant species and the circumstances under which a bioluminescent reaction is desired. Phototransformation may be utilized to vary the wavelength of light emitted from the mature plant.

7663022, Feb 16, 2010

May 18, 2006

11/419108

Bruce Eric Hudkins - Tulsa OK, US

C12N 15/82, C12N 15/84, C12N 15/31, C12N 15/53, C12N 15/62, A01H 5/00

800282, 800287, 800288, 800294, 800300, 800303, 435 8, 435 698, 435189, 435468, 435469

Transgenic plants, and a method for making the same, wherein genes encoding the enzyme luciferase and its corresponding substrate luciferin are incorporated into a native plant genome. Once transformed into plant cells, these genes may be regulated such that under certain endogenous or exogenous conditions, their expression in the mature plant results in bioluminescence. Different luciferin/luciferase complexes and/or mechanisms of regulation may be utilized for these transgenic plants, depending on a variety of factors such as plant species and the circumstances under which a bioluminescent reaction is desired. Phototransformation may be utilized to vary the wavelength of light emitted from the mature plant.

7563464, Jul 21, 2009

Oct 30, 2007

11/929086

Bruce Eric Hudkins - Tulsa OK, US
Thomas G. Matkov - Lake Bluff IL, US

A01N 65/00, A61K 36/48, A61F 13/00

424725, 424757, 424434

A composition and method for direct application to mucosal membranes, which combines naturally occurring phytoestrogens, such as plant extracts and soy isoflavones, with other active and inactive ingredients in a convenient medium, such as an aqueous cream, aqueous spray or suppository. The composition may be used for the treatment of dry or inadequately hydrated mucosal surfaces, and related complications, such as those affecting the nasal passages or vagina.

7049483, May 23, 2006

Jul 15, 2002

10/195283

Bruce Eric Hudkins - Tulsa OK, US

C12N 15/82, C12N 15/12, C12N 15/53, A01H 5/00

800282, 800271, 800287, 800288, 800303, 435 698, 435189

Transgenic plants are created having incorporated into them a luciferase enzyme gene and a corresponding luciferin substrate gene. These genes are regulated such that for a certain amount of time after dark, these genes are expressed resulting in bioluminescence. Different luciferin/luciferase combinations may be utilized for these transgenic plants, depending on the desired wavelength and the plant species transfected.